LaserAway, a US medspa and aesthetic dermatology operator backed by Ares Management and Seidler Equity Partners, is exploring a potential sale that could value the business at more than $2bn, according to a report by Reuters citing unnamed people familiar with the situation.
The Los Angeles-based company has engaged investment bank Harris Williams to advise on a process that is still in its early stages, the sources said. The discussions remain confidential and no final decision has been made re...
Continue Reading
Sign up for FREE to read the full article and access 151K+ alternative investment headlines.
Alternative Investment News